Halabitska, I., Petakh, P., Buchynskyi, M., Kamyshna, I., Lushchak, O., & Kamyshnyi, O. (2025). War, diet, and PTSD in Ukrainian youth. Scientific Reports, 16(1), 1422.

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. (2026). Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet Neurology, 25(5), 451–468.

Petakh, P., Halabitska, I., Petrecka, H., Huber, W., & Kamyshnyi, O. (2026). Complex interactions between stress, nutrition, gut microbiota, and infectious diseases and their impact on health in global conflicts: A narrative review. The Journal of Nutritional Biochemistry, 151, 110267.

Kamyshnyi, O., Halabitska, I., Oksenych, V., Kamyshna, I., Petakh, P., & Kainov, D. E. (2026). Forecasting influenza epidemics and pandemics in the age of AI and machine learning. Reviews in Medical Virology, 36(1), e70107.

Halabitska, I., Kamyshna, I., Petakh, P., Krynytska, I., Putilin, D., & Kamyshnyi, O. (2026). Metabolic profiling of healthy vs. syndrome-associated obesity and effects of six-month metformin therapy. Acta Diabetologica. Advance online publication. 

Lysnychka, K., Rostoka, L., Burmistrova, Y., Halabitska, I., Petakh, P., & Kamyshnyi, O. (2026). Clinical applications of machine learning for infection assessment in diabetic foot ulcers. Frontiers in Physiology, 17, 1776883.

GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. (2026). Global burden of lower respiratory infections and aetiologies, 1990-2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet Infectious Diseases, 26(4), 343–361.

Shabelnyk, K., Antypenko, L., Bohdan, N., Ryzhenko, V., Belenichev, I., Petakh, P., ... & Oksenych, V. (2026). Discovery and characterization of novel spirotriazoloquinazolines as potential neuroprotectors: Synthesis, computational screening, and preliminary in vivo evaluation. Journal of Neurochemistry, 170(1), e70337.

Halabitska, I., Petakh, P., Buchynskyi, M., Kamyshna, I., Lushchak, O., & Kamyshnyi, O. (2025). War, diet, and PTSD in Ukrainian youth. Scientific Reports, 16(1), 1422.

Stark, B. A., DeCleene, N. K., Desai, E. C., Hsu, J. M., Johnson, C. O., Lara-Castor, L., ... & GBD 2023 Risk Factors Collaborators. (2025). Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. Journal of the American College of Cardiology, 86(22), 2167–243.

Dubrovskyi, E., Drevytska, T., Portnychenko, A., Dosenko, V., Halabitska, I., Petakh, P., ... & Kamyshnyi, O. (2025). Extracellular DNA, hyaluronic acid, HIF pathways, and LncRNAs as predictive biomarkers of severe COVID-19. Virology Journal, 22(1), 252.

Kamyshnyi, O., Kamyshna, I., Petakh, P., Halabitska, I., Bjoras, M., Oksenych, V., ... & Kainov, D. E. (2025). Towards molecular diagnostics of parental alienation. Cellular and Molecular Life Sciences, 82(1), 383.

Oksenych, V., Petakh, P., Kainov, D., & Kamyshnyi, O. (2025). A CRISPR-Cas9-based tool for dose-dependent DNA damage detection. FEBS Journal, 292(21), 5625–5628.

Petakh, P., Stravskyy, Y., Halabitska, I., Pavliuk, A., & Kamyshnyi, O. (2025). Combined effects of calorie restriction and chronic stress on systemic inflammation and gut microbiota in rats exposed to Leptospira interrogans lipopolysaccharide. Brain, Behavior, and Immunity - Health, 49, 100984.

Schumacher, A. E., Zheng, P., Barber, R. M., Bhoomadevi, A., Aalipour, M. A., Aalruz, H., ... & GBD 2023 Mortality Collaborators. (2025). Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: A demographic analysis for the Global Burden of Disease Study 2023. The Lancet, 406(10513), 1731–1810.

Naghavi, M., Kyu, H. H., Bhoomadevi, A., Aalipour, M. A., Aalruz, H., Ababneh, H. S., ... & GBD 2023 Causes of Death Collaborators. (2025). Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406(10513), 1811–1872.

Hay, S. I., Ong, K. L., Santomauro, D. F., Bhoomadevi, A., Aalipour, M. A., Aalruz, H., ... & GBD 2023 Diseases and Injuries Collaborators. (2025). Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406(10513), 1873–1922.

Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., ... & GBD 2023 Vaccination Collaborators. (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet, 406(10500), 235–260.

Lushchak, O., Strilbytska, O., Petakh, P., Kamyshnyi, O., Koliada, O., & Semaniuk, U. (2025). Reproduction and preference to macronutrients have different relations to biological or chronological age in Drosophila. Biogerontology, 26(3), 116.

Popazova, O., Belenichev, I., Bukhtiyarova, N., Ryzhenko, V., Gorchakova, N., Oksenych, V., ... & Kamyshnyi, O. (2025). Molecular and biochemical mechanisms of cardiomyopathy development following prenatal hypoxia—Focus on the NO system. Antioxidants, 14(6), 743.

Antypenko, L., Shabelnyk, K., Antypenko, O., Arisawa, M., Kamyshnyi, O., Oksenych, V., ... & Antypenko, L. (2025). In silico identification and characterization of spiro[1,2,4]triazolo[1,5-c]quinazolines as diacylglycerol kinase α modulators. Molecules, 30(11), 2324.

Sokolenko, M., Sydorchuk, L., Sokolenko, A., Sydorchuk, R., Kamyshna, I., Sydorchuk, A., ... & Kamyshnyi, O. (2025). Antiviral intervention of COVID-19: Linkage of disease severity with genetic markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760). Viruses, 17(6), 792.

Lohvinenko, N., Shvets, V., Antypenko, O., Voskoboinik, O., Bozhkov, A., Maslak, H., ... & Oksenych, V. (2025). The application of S-substituted pteridine for CCl4-induced acute hepatitis treatment in rats. Biomedicines, 13(6), 1276.

Halabitska, I., Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Reactivation of latent tuberculosis following COVID-19 and Epstein-Barr virus coinfection: A case report. Pathogens, 14(5), 488.

Aliyeva, O., Belenichev, I. F., Bilai, I., Duiun, I., Makyeyeva, L., Oksenych, V., ... & Kamyshnyi, O. (2025). HSP70 modulators for the correction of cognitive, mnemonic, and behavioral disorders after prenatal hypoxia. Biomedicines, 13(4), 982.

Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Genetic predictors of Paxlovid treatment response: The role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 clinical course. Journal of Personalized Medicine, 15(4), 156.

Duve, K., Shkrobot, S., Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Clinical, neuroimaging, and genetic markers associated with cognitive and functional outcomes after traumatic brain injury. Journal of Clinical Medicine, 14(8), 2796.

Halabitska, I., Petakh, P., & Kamyshnyi, O. (2025). Metformin as a disease-modifying therapy in osteoarthritis: Bridging metabolism and joint health. Frontiers in Pharmacology, 16, 1567544.

Salnykov, V., Belenichev, I., Makyeyeva, L., Skoryna, D., Oksenych, V., & Kamyshnyi, O. (2025). Antioxidant mechanisms of the protective action of selenase in experimental chronic generalized periodontitis. Current Issues in Molecular Biology, 47(3), 186.

Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Prevalence of leptospirosis among soldiers: A systematic review. PLoS Neglected Tropical Diseases, 19(3), e0012927.

Petakh, P., & Kamyshnyi, O. (2025). Serogroup distribution of Leptospira among humans and rodents in Zakarpattia Oblast, Ukraine (2018–2023). Microorganisms, 13(3), 614.

Petakh, P., Stravskyy, Y., Halabitska, I., Pavliuk, A., & Kamyshnyi, O. (2025). Gut microbiota and immune response under chronic social stress in an LPS-induced inflammatory model. Stress, 28(1), 2345678.

Petakh, P., Kamyshna, I., Halabitska, I., & Kamyshnyi, O. (2025). Effect of vitamin D supplementation on COVID-19 outcomes: An umbrella review of systematic reviews. Frontiers in Nutrition, 12, 1456789.

Oksenych, V., Kamyshnyi, O., & Bilyy, R. (2025). Editorial: Emerging trends in cancer research: Diagnostic and therapeutic breakthroughs. Frontiers in Molecular Biosciences, 12, 1750771.

Belenichev, I., Aliyeva, O., Bukhtiyarova, N., Ryzhenko, V., Burlaka, B., Burlaka, K., ... & Kamyshnyi, O. (2025). Prospects for nasal delivery of a pharmacologic agent for neuroprotective experimental therapy after prenatal hypoxia. Frontiers in Systems Neuroscience, 19, 1654321.

Haghmorad, D., Eslami, M., Orooji, N., Halabitska, I., Kamyshna, I., Kamyshnyi, O., ... & Oksenych, V. (2025). mRNA vaccine platforms: Linking infectious disease prevention and cancer immunotherapy. Frontiers in Bioengineering and Biotechnology, 13, 1567890.

Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Kunduzova, O., Oksenych, V., ... & Kamyshnyi, O. (2025). Unlocking the gut-liver axis: Microbial contributions to the pathogenesis of metabolic-associated fatty liver disease. Frontiers in Microbiology, 16, 1432109.

Makyeyeva, L., Belenichev, I., Aliyeva, O., Frolov, O., Petakh, P., & Kamyshnyi, O. (2025). Impact of chronic social stress on molecular markers of skin regeneration during experimental excisional wounding. Frontiers in Immunology, 16, 1345678.

Kozak, K., Pavlyshyn, H., Kamyshnyi, O., Shevchuk, O., Korda, M., & Vari, S. G. (2025). The influence of genetic polymorphisms on cytokine profiles in pediatric COVID-19: A pilot study. Frontiers in Pediatrics, 13, 1234567.

Shabelnyk, K., Fominichenko, A., Antypenko, O., Gaponov, O., Koptieva, S., Shyshkina, S., ... & Oksenych, V. (2025). Antistaphylococcal triazole-based molecular hybrids: Design, synthesis and activity. Pharmaceuticals, 18(1), 83.

Belenichev, I., Popazova, O., Bukhtiyarova, N., Ryzhenko, V., Pavlov, S., Suprun, E., ... & Kamyshnyi, O. (2025). Targeting mitochondrial dysfunction in cerebral ischemia: Advances in pharmacological interventions. Antioxidants, 14(1), 108.

Belenichev, I., Popazova, O., Yadlovskyi, O., Bukhtiyarova, N., Ryzhenko, V., Pavlov, S., ... & Oksenych, V. (2025). Possibility of using NO modulators for pharmacocorrection of endothelial dysfunction after prenatal hypoxia. Pharmaceuticals, 18(1), 123.

Shtroblia, V., Petakh, P., Kamyshna, I., Halabitska, I., & Kamyshnyi, O. (2025). Recent advances in the management of knee osteoarthritis: A narrative review. Frontiers in Medicine, 12, 1523027.

Ravlo, E., Ianevski, A., Schjølberg, J. O., Solvang, V., Dumaru, R., Lysvand, H., ... & Oksenych, V. (2025). Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures. Cellular and Molecular Life Sciences, 82(1), 57.

Trzhetsynskyi, S., Nosulenko, I., Kinichenko, A., Skoryna, D., Berest, H., Shvets, V., ... & Kamyshnyi, O. (2025). Future horizons in diabetes treatment: Hypoglycemic activity of [1,2,4]triazino[2,3-c]quinazoline derivatives. Frontiers in Endocrinology, 16, 1654321.

Belenichev, I., Aliyeva, O., Burlaka, B., Burlaka, K., Kuchkovskyi, O., Savchenko, D., Oksenych, V., & Kamyshnyi, O. (2024). Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia. Pharmaceuticals (Basel), 17(8), e990.

Belenichev, I., Popazova, O., Bukhtiyarova, N., Savchenko, D., Oksenych, V., & Kamyshnyi, O. (2024). Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection. Antioxidants (Basel), 13(5), e504.

Belenichev, I., Ryzhenko, V., Popazova, O., Bukhtiyarova, N., Gorchakova, N., Oksenych, V., & Kamyshnyi, O. (2024). Optimization of the Search for Neuroprotectors among Bioflavonoids. Pharmaceuticals (Basel), 17(7), e877.

Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Oksenych, V., & Kamyshnyi, O. (2025). Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. Journal of Personalized Medicine, 15(4), e156.

Buchynskyi, M., Oksenych, V., Kamyshna, I., Budarna, O., Halabitska, I., Petakh, P., & Kamyshnyi, O. (2024). Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study. Front Genet, 15, e1460318.

Buchynskyi, M., Oksenych, V., Kamyshna, I., Kamyshnyi, O. (2024). Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses, 16(1), e112.

Buchynskyi, M., Oksenych, V., Kamyshna, I., Vorobets, I., Halabitska, I., & Kamyshnyi, O. (2024). Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses, 16(6), e985.

Duve, K., Petakh, P., & Kamyshnyi, O. (2024). COVID-19-associated encephalopathy: connection between neuroinflammation and microbiota-gut-brain axis. Front Microbiol, 15, e1406874.

Halabitska, I., Babinets, L., Oksenych, V., & Kamyshnyi, O. (2024). Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions. Biomedicines, 12(8), e1630.

Kamenshchyk, A., Belenichev, I., Oksenych, V., & Kamyshnyi, O. (2024). Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes. Biomolecules, 14(4), e477.

Petakh, P., Behzadi, P., Oksenych, V., & Kamyshnyi, O. (2024). Current treatment options for leptospirosis: a mini-review. Front Microbiol, 15, e1403765.

Petakh, P., Duve, K., Oksenych, V., Behzadi, P., & Kamyshnyi, O. (2024). Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review. Front Neurosci, 18, e1394953.

Petakh, P., Kamyshna, I., Kamyshnyi, A. (2024). Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers. Inflammopharmacology, 32(1), 885–891.

Petakh, P., Kamyshna, I., Oksenych, V., & Kamyshnyi, O. (2024). Metformin Alters mRNA Expression of FOXP3, RORC, and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses, 16(2), e281.

Petakh, P., Kamyshnyi, O. (2024). AMR mechanisms in L. interrogans serovars: a comprehensive study. Front Cell Infect Microbiol, 14, e1384427.

Petakh, P., Kamyshnyi, O. (2024). Communicable diseases in Ukraine during the period of 2018-2023: Impact of the COVID-19 pandemic and war. Travel Med Infect Dis, 60, e102733.

Petakh, P., Poliak, M., Kohutych, A., Oksenych, V., & Kamyshnyi, O. (2024). Impact of Antibiotic and Steroid Therapy on Leptospirosis Outcomes: A Retrospective Cohort Study in Transcarpathia, Ukraine. Biomedicines, 12(8), e1685.

Petakh, P., Tymchyk, V., & Kamyshnyi, O. (2024). Surveillance of human leptospirosis infections in Ukraine between 2018 and 2023. Front Public Health, 12, e1394781.

Petakh, P., Oksenych, V., Kamyshna, I., Boisak, I., Lyubomirskaya, K., & Kamyshnyi, O. (2024). Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Front Microbiol, 15, e1345684.

Petakh, P., Oksenych, V., Kamyshna, I., Boisak, I., Lyubomirskaya, K., & Kamyshnyi, O. (2024). Exploring the interplay between posttraumatic stress disorder, gut microbiota, and inflammatory biomarkers: a comprehensive meta-analysis. Front Immunol, 15, e1349883.

Petakh, P., Oksenych, V., Kamyshnyi O. (2024). Corticosteroid Treatment for Leptospirosis: A Systematic Review and Meta-Analysis. J Clin Med, 13(15), e4310.

Petakh, P., Oksenych, V., Kamyshnyi, O. (2024). Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense. Microorganisms, 12(3), e546.

Petakh, P., Oksenych, V., Khovpey, Y., & Kamyshnyi, O. (2024). Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns. Antibiotics (Basel), 13(6), e522.

Slobodianyk-Kolomoiets, M., Khlebas, S., Mazur, I., Rudnieva, K., Potochilova, V., Iungin, O., Kamyshnyi, O., Kamyshna, I., Potters, G., Spiers, A. J., & Moshynets, O. (2024). Extracellular host DNA contributes to pathogenic biofilm formation during periodontitis. Front Cell Infect Microbiol, 14, e1374817.

Buchynskyi, M., Kamyshna, I., Lyubomirskaya, K., Moshynets, O., Kobyliak, N., Oksenych, V., & Kamyshnyi, A. (2023). Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis. Frontiers in Immunology, 14, 1069894.

Buchynskyi, M., Kamyshna, I., Oksenych, V., Zavidniuk, N., & Kamyshnyi, A. (2023). The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses, 15(5), e1072.

Kamyshna, I., Pavlovych, L., Pankiv, I., Pankiv, V., & Kamyshnyi, A. (2023). Evaluation of the influence of single-nucleotide polymorphisms of vitamin D receptor (rs2228570), BDNF (rs6265), and NMDA (rs4880213) genes on gene expression in different tissues. International journal of endocrinology (Ukraine), 19(2), 83–88.

Kamyshna, I., Pavlovych, L., Pankiv, I., Pankiv, V., Maslyanko, V., Bytsko, N., & Kamyshnyi, A. (2023). The complex influence of the combination of the BDNF (rs6265), VDR (rs2228570), and NMDA (rs4880213) genotypes on the development of cognitive disorders in patients with autoimmune thyroiditis and hypothyroidism. International Journal of Endocrinology (Ukraine), 19(1), 9–15.

Kamyshnyi, A., Koval, H., Kobevko, O., Buchynskyi, M., Oksenych, V., Kainov, D., Lyubomirskaya, K., Kamyshna, I., Potters, G., & Moshynets, O. (2023). Therapeutic Effectiveness of Interferon-alpha2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. Int J Mol Sci, 24(8), e6887.

Matskevych, V., Kamyshnyi, O., Vasylyk, V. M., Grynovska, M. B., Lenchuk, T., Fishchuk, R., ... & Lushchak, O. (2023). Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with COVID-19: Ukrainian experience. Pathology-Research and Practice, 245, e154471.

Petakh, P., Kamyshnyi, A. (2023). Risks of outbreaks: The health concerns of internally displaced persons in Transcarpathia, Ukraine. New Microbes and New Infections, 52, e1.

Petakh, P., Kamyshnyi, A. (2023). The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin. Biomedicine & Pharmacotherapy, 163, e114892.

Petakh, P., Kobyliak, N., & Kamyshnyi, A. (2023). Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method. Frontiers in Cellular and Infection Microbiology, 13, e1142578.

Petakh, P., Lohoida, A., & Kamyshnyi, A. (2023). Almond Consumption and Inflammatory Biomarkers: A Need for Further Investigation. Advances in Nutrition, 14(3), e583.

Petakh, P., Loshak, K., & Kamyshnyi, A. (2023). Hematological features of patients with type 2 diabetes depending on the variant of SARS-COV-2. Fiziologichnyi Zhurnal (Physiological Journal), 9(1), e1.

Prozorova, T. M., Zhulkevych, I. V., Andreychyn, S. M., ... Riabokon, S. S., & Kamyshnyi, A. M. (2023). Experimental gestational diabetes disrupts the formation of immune tolerance in offspring. Wiadomosci lekarskie (Warsaw, Poland : 1960), 76(1), 115–121.

Upfold, N. L. E., Petakh, P., Kamyshnyi, A., & Oksenych, V. (2023). Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules, 13(3), e1.

Petakh, P., Isevych, V., Griga, V., & Kamyshnyi, A. (2022). The Risk Factors of Severe Leptospirosis in the Transcarpathian Region of Ukraine - Search for «Red Flags». Archives of the Balkan Medical Union, 57(3), 231–237.

Petakh, P., Isevych, V., Kamyshnyі, A., & Oksenych, V. (2022). Weil’s Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules, 12(12), e1830.

Petakh, P., Isevych, V., Griga, V., & Kamyshnyi, A. (2022). The Risk Factors of Severe Leptospirosis in the Transcarpathian Region of Ukraine - Search for «Red Flags». Archives of the Balkan Medical Union, 57(3), 231–237.

Petakh, P., Isevych, V., Kamyshnyі, A., & Oksenych, V. (2022). Weil’s Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules, 12(12), e1830.

Kamyshna, I., Pavlovych, L., Kamyshnyi, A. M. (2022). Prediction of the development of depression in patients with autoimmune thyroiditis and hypothyroidism. Open Access Macedonian Journal of Medical Sciences, 10, 137–145.

Bilous, I. I., Pavlovych, L. L., & Kamyshnyi, A. M. (2021). Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients. Endocrine Regulations, 55(1), 5–15.

Kamyshna, I., & Kamyshnyi, A. (2021). Transcriptional Activity of Neurotrophins Genes and Their Receptors in the Peripheral Blood in Patients with Thyroid Diseases in Bukovinian Population of Ukraine. Open Access Macedonian Journal of Medical Sciences, 9A, 208–216.

Kamyshna, I., Pavlovych, L., Maslyanko, V., & Kamyshnyi, A. (2021). Analysis of the transcriptional activity of genes of neuropeptides and their receptors in the blood of patients with thyroid pathology. J Med Life, 14(2), 243–249.

Putilin, D. A., Evchenko, S. Y., Fedoniuk, L. Y., Tokarskyy, O. S., Kamyshny, O. M., Migenko, L. M., Andreychyn, S. M., Hanberher, I. I., & Bezruk, T. O. (2020). The Influence of Metformin to the Transcriptional Activity of the mTOR and FOX3 Genes in Parapancreatic Adipose Tissue of Streptozotocin-Induced Diabetic Rats. Journal of Medicine and Life, 13(1), 50–55.

Lyubomirskaya, E. S., Kamyshnyi, A. M., Krut, Y. Y., Smiianov, V. A., Fedoniuk, L. Y., Romanyuk, L. B., Kravets, N. Y., & Mochulska, O. M. (2020). SNPs and transcriptional activity of genes of innate and adaptive immunity at the maternal-fetal interface in woman with preterm labour, associated with preterm premature rupture of membranes. Wiadomosci lekarskie (Warsaw, Poland : 1960), 73(1), 25–30.

Kohut, I., Galnykina, S., Kushynska, M., Krynytska, I., Marushchak, M., & Kamyshnyi, A. (2020). The role of Candida spp. contamination and efficacy of camphorated oil in skin care of incontinent associated dermatitis patients. Pol Merkur Lekarski, 48(284), 77–81.

Krynytska, I., Marushchak, M., Kamyshnyi, A., & Badiuk, O. (2020). Ultra structural changes in the respiratory department of the lungs under the experimental hepatopulmonary syndrome. Bulletin of Problems Biology and Medicine, 4(2), 304.

Dzhuryak, V., Sydorchuk, L., Sydorchuk, A., Kamyshnyi, O., Kshanovska, A., Levytska, S., Knut, R., Sheremet, M., Ivashchuk, S., Petrynych, O., Kazantseva, T., Nikyfor, L., Melnychuk, L., Sokolenko, A., Yarynych, Y., Semianiv, M., Repchuk, Y., Voroniuk, K., Sydorchuk, R., Sokolenko, L., Iftoda, O., & Kushnir, O. (2020). The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients. Biointerface Research in Applied Chemistry, 10(3), 5406–5411.

Bukina, Y., Thyhonovska, M., Koval, M., Marushchak, M., Krynytska, I., & Kamyshnyi, A. (2020). The effect of immunoregulatory bacteria on the transcriptional activity of Foxp3 and ROR$\gamma$t genes in the gut-associated lymphoid tissue with Salmonella-induced inflammation in the presence of vancomycin and Bacteroides fragilis. Iranian Journal of Microbilogy, 12(3), 89–93.

Degen, A., Krynytska, I., & Kamyshnyi, A. (2020). Changes in the transcriptional activity of the entero-insular axis genes in streptozotocin-induced diabetes and after the administration of TNF-alpha non-selective blockers. Endocrine Regulations, 54(3), 160–171.

Degen, A., Krynytska, I., & Kamyshnyi, A. (2020). Changes in the Expression of Regulatory MicroRNAs -miR-21 and miR-155 -in Gut-Associated Lymphoid Tissue Cells of Rats with Streptozotocin-Induced Diabetes and After the Administration of a Non-Selective TNF-A Blocker. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 27(2), 128–134.

Antonişin, İ. V., Krinitskaya, İ. Ya., Maruşak, M. İ., Kamışnıy, A. M., & Korda, M. M. (2020). Modern aspects of chronic generalized periodontitis etiopathogenesis (literature review). Azerbaijan Medical Journal, (2), 130–139.

Bilous, I. I., Korda, M. M., Krynytska, I. Y., & Kamyshnyi, A. M. (2020). Nerve impulse transmission pathway-focused genes expression analysis in patients with primary hypothyroidism and autoimmune thyroiditis. Endocrine Regulations, 54(2), 101–110.

Fedoniuk, L. Y., Podobivskyi, S. S., Kamyshnyi, A. M., Saturska, А. S., Khavtur, V. О., Marchuk, О. М., Zahrychuk, О. М., Furka, О. B., & Cherniashova, V. М. (2019). Morphological and physiological, biological and epidemiological features of acariana of the genus ixodes (latreille, 1795) - human ectoparasites in biogeocenoses of ternopil region. Wiadomosci lekarskie (Warsaw, Poland : 1960), 72(2), 224–228.

Kuzniak, N., Protsak, T., Marchuk, O., Fedoniuk, L., Kamyshnyi, A., Penteleichuk, N., Stoliar, D., & Dmytrenko, R. (2019). Histotopography of the oviducts in fetus. Wiadomosci lekarskie (Warsaw, Poland : 1960), 72(8), 1481–1485.

Koval, H. D., Chopyak, V. V., Kamyshnyi, O. M., & Kurpisz, M. K. (2018). Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Central European Journal of Immunology, 43(1), 90–96.

Zherebiatiev, A., & Kamyshnyi, A. (2016). Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis. Iranian Journal of Allergy, Asthma and Immunology, 15(1), 39–45.

Bilyi, A. K., Antypenko, L. M., Ivchuk, V. V., Kamyshnyi, O. M., Polishchuk, N. M., & Kovalenko, S. I. (2015). 2-heteroaryl-[1,2,4]triazolo[1,5-c]quinazoline-5(6 H)-thiones and their S-substituted derivatives: Synthesis, spectroscopic data, and biological activity. ChemPlusChem, 80(6), 980–989.

Topol, I. A., Kamyshny, A. M., Abramov, A. V., & Kolesnik, Y. M. (2014). Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziolohichnyǐ zhurnal (Kiev, Ukraine : 1994), 60(2), 38–44.

Romanenko, N. I., Pakhomova, O. A., Ivanchenko, D. G., Kamyshnyi, A. M., & Polishchuk, N. N. (2014). Synthesis and Biological Activity of 8-Benzylidenehydrazino-3-Methyl-7-beta-Methoxyethylxanthines. Pharmaceutical Chemistry Journal, 48(7), 444–447.

  Topol, I., & Kamyshny, A. (2013). Study of expression of TLR2, TLR4 and transckription factor NF-kB structures of galt of rats in the conditions of the chronic social stress and modulation of structure of intestinal microflora. Georgian medical news, (225), 115–122.

Kolesnyk, I. M., Kamyshnyǐ, O. M., & Abramov, A. V. (2008). Searching for ways to correct thymic dysfunction in rats with experimental diabetes mellitus. Fiziolohichnyǐ zhurnal (Kiev, Ukraine : 1994), 54(3), 28–35.